Novavax
NVAX
250 hedge funds and large institutions have $895M invested in Novavax in 2025 Q3 according to their latest regulatory filings, with 46 funds opening new positions, 73 increasing their positions, 76 reducing their positions, and 45 closing their positions.
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
39% more capital invested
Capital invested by funds: $643M → $895M (+$252M)
1.45% more ownership
Funds ownership: 62.1% → 63.55% (+1.4%)
2% more first-time investments, than exits
New positions opened: 46 | Existing positions closed: 45
0% less funds holding
Funds holding: 251 → 250 (-1)
4% less repeat investments, than reductions
Existing positions increased: 73 | Existing positions reduced: 76
24% less call options, than puts
Call options by funds: $76.9M | Put options by funds: $101M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TCMG
TSP Capital Management Group
Summit,
New Jersey
|
+$10.9M |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$9.81M |
| 3 |
Allianz Asset Management
Munich,
Germany
|
+$6.79M |
| 4 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$5.95M |
| 5 |
HF
HRT Financial
New York
|
+$4.9M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
-$6.29M |
| 2 |
JAM
Jupiter Asset Management
London,
United Kingdom
|
-$6.07M |
| 3 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
-$3.83M |
| 4 |
TCM
Tang Capital Management
San Diego,
California
|
-$3.78M |
| 5 |
Group One Trading
Chicago,
Illinois
|
-$3.73M |
NVAX Hedge Fund Activity: Q3 2025 in Review
250 of the 7,641 institutional investors tracked by Wall St. Rank reported a position in Novavax (NVAX) for Q3 2025, worth a combined $895M — up 39% from $643M a quarter earlier.
Buyers outnumbered sellers: 46 funds opened new NVAX positions and 45 closed out — a net gain of 1 holder — while 73 added to existing stakes and 76 trimmed.
The largest buyer was TSP Capital Management Group, opening a new position worth an estimated $10.9M. The largest seller was Deep Track Capital, exiting entirely with an estimated $6.29M sold.
- 250 institutional investors held Novavax (NVAX) as of Q3 2025, down from 251 in Q2 2025.
- Funds reported $895M of Novavax stock for Q3 2025, up 39% quarter-over-quarter.
- 46 funds opened new Novavax positions in Q3 2025 and 45 closed out, a net change of +1 holder.
- The largest Novavax buyer in Q3 2025 was TSP Capital Management Group, an estimated $10.9M added.
- The largest Novavax seller in Q3 2025 was Deep Track Capital, an estimated $6.29M sold.
Based on aggregated 13F filings for Q3 2025.